Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 1.94% |
| 2 | Technology | 1.9% |
| 3 | Communication Services | 1.42% |
| 4 | Financials | 1.08% |
| 5 | Healthcare | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FAZ
1726
CALL
Direxion Daily Financial Bear 3x ETF
FAZ
$87M
| $26M | ﹤0.01% |
97,140
-1,630
| -2% | -$455K |
|
1727
BioCryst Pharmaceuticals
BCRX
$2.51B
| $26M | ﹤0.01% |
1,641,950
-452,495
| -22% | -$6.15M |
|
1728
CALL
Restaurant Brands International
QSR
$28.4B
| $26M | ﹤0.01% |
402,800
-189,300
| -32% | -$12.8M |
|
1729
PUT
Air Products & Chemicals
APD
$67.7B
| $25.8M | ﹤0.01% |
89,800
-17,600
| -16% | -$5.17M |
|
1730
PUT
Vail Resorts
MTN
$5.27B
| $25.8M | ﹤0.01% |
81,600
+39,700
| +95% | +$12.7M |
|
|
FFAI
1731
CALL
Faraday Future Intelligent Electric
FFAI
$10.7M
| $25.8M | ﹤0.01% |
1
| – | – |
|
|
MRSH
1732
Marsh
MRSH
$92.3B
| $25.8M | ﹤0.01% |
183,348
+84,286
| +85% | +$11.3M |
|
1733
NRG Energy
NRG
$23.9B
| $25.8M | ﹤0.01% |
639,615
+458,601
| +253% | +$16.6M |
|
|
TIGR
1734
CALL
UP Fintech Holding
TIGR
$976M
| $25.8M | ﹤0.01% |
889,200
-115,400
| -11% | -$2.46M |
|
1735
CALL
Cadence Design Systems
CDNS
$91.4B
| $25.8M | ﹤0.01% |
188,200
-40,400
| -18% | -$5.35M |
|
1736
CALL
Vulcan Materials
VMC
$35.5B
| $25.7M | ﹤0.01% |
147,700
+33,500
| +29% | +$5.99M |
|
|
WW
1737
CALL
DELISTED
WW International
WW
| $25.6M | ﹤0.01% |
708,600
-490,000
| -41% | -$16.8M |
|
1738
PUT
Transocean
RIG
$6.42B
| $25.6M | ﹤0.01% |
5,660,500
+285,400
| +5% | +$1.08M |
|
|
WLL
1739
PUT
DELISTED
Whiting Petroleum Corporation
WLL
| $25.6M | ﹤0.01% |
468,700
-27,600
| -6% | -$1.19M |
|
|
FISV
1740
Fiserv Inc
FISV
$27.9B
| $25.5M | ﹤0.01% |
238,923
-86,488
| -27% | -$10.1M |
|
1741
Agnico Eagle Mines
AEM
$113B
| $25.5M | ﹤0.01% |
422,382
-169,478
| -29% | -$11.3M |
|
1742
PUT
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.55B
| $25.4M | ﹤0.01% |
627,700
-315,300
| -33% | -$12.6M |
|
1743
UiPath
PATH
$8.63B
| $25.4M | ﹤0.01% |
+374,101
| New | +$27.4M |
|
|
ABMD
1744
CALL
DELISTED
Abiomed Inc
ABMD
| $25.3M | ﹤0.01% |
81,200
-10,700
| -12% | -$3.28M |
|
1745
Kimberly-Clark
KMB
$36.9B
| $25.3M | ﹤0.01% |
189,345
+128,126
| +209% | +$17.1M |
|
1746
PUT
Vodafone
VOD
$37.3B
| $25.3M | ﹤0.01% |
1,478,600
+908,900
| +160% | +$17M |
|
1747
CALL
Smith & Wesson
SWBI
$606M
| $25.3M | ﹤0.01% |
729,800
+630,800
| +637% | +$13.2M |
|
1748
Okta
OKTA
$22.8B
| $25.3M | ﹤0.01% |
103,368
-8,185
| -7% | -$1.98M |
|
1749
RTX Corp
RTX
$283B
| $25.3M | ﹤0.01% |
296,155
-98,841
| -25% | -$8.32M |
|
1750
PUT
Eaton
ETN
$159B
| $25.2M | ﹤0.01% |
170,100
-71,300
| -30% | -$10.3M |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.7% a quarter earlier, followed by Technology and Communication Services.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.